Skip to main content
. 2021 Jun 11;8(8):e495–e501. doi: 10.1016/S2352-3018(21)00048-5

Table 1.

Description of follow-up time, including demographics and HIV sexual risk behaviours

Study visits with PrEP access
180 days before and after PrEP access
Before access After access Before access After access
Number of women 4582 2119 3675 2032
Person-years 2860 556 919 481
Baseline VOICE risk score*
0–4 1633/4582 (36%) 776/2119 (37%) 1336/3675 (36%) 751/2032 (37%)
5–9 2931/4582 (64%) 1336/2119 (63%) 2326/3675 (64%) 1274/2032 (63%)
Median age, years 23 (20–26) 23 (21–27) 23 (20–27) 23 (21–27)
Number of visits 10 278 2446 3774 2160
Study month
6 months .. .. 51/3774 (14%) ..
9 months .. .. 797/3774 (21%) 13/2160 (1%)
12 months 4063/10 278 (40%) 593/2446 (24%) 735/3774 (19%) 585/2160 (27%)
15 months 3432/10 278 (33%) 967/2446 (40%) 777/3774 (21%) 835/2160 (39%)
18 months 2783/10 278 (27%) 886/2446 (36%) 955/3774 (25%) 727/2160 (34%)
Number of sexual partners
0 278/10 278 (3%) 77/2446 (3%) 86/3774 (2%) 66/2160 (3%)
1 9366/10 278 (91%) 2236/2446 (91%) 3463/3774 (92%) 1972/2160 (91%)
2 630/10 278 (6%) 131/2446 (5%) 225/3774 (6%) 122/2160 (6%)
Partner has other sexual partners
No 3336/10 278 (32%) 812/2446 (33%) 1216/3774 (32%) 711/2160 (33%)
Yes 1003/10 278 (10%) 212/2446 (9%) 398/3774 (11%) 186/2160 (9%)
Do not know 5935/10 278 (58%) 1420/2446 (58%) 2160/3774 (57%) 1263/2160 (58%)
Ever initiated PrEP at or before this visit 270/10 278 (3%) 612/2446 (25%) 17/3774 (0%) 536/2160 (25%)
Reported any unprotected sex 6667/10 278 (65%) 1628/2446 (67%) 2459/3774 (65%) 1434/2160 (66%)
New partner 544/10 278 (5%) 112/2446 (5%) 196/3774 (5%) 105/2160 (5%)

Data are n, n (%), or median (IQR). PrEP=pre-exposure prophylaxis.

*

VOICE risk score has been validated as a predictor of HIV incidence in African women and includes the following factors: age <25 years; unmarried or not living with partner; partner does not provide financial or material support; primary partner has other partners (yes or do not know); alcohol use in the past 3 months; or having a curable sexually transmitted infection. VOICE risk score was measured at baseline and is a characteristic of the woman at enrollment. All other covariates were assessed at every visit.

For 227 (88%) of these women, their PrEP initiation date was between ECHO quarterly visits and after initiation of on-site PrEP access. These intervals with partial PrEP access are included in the before access data.